These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33472009)

  • 1. Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why.
    Ray LA; Grodin EN
    Annu Rev Clin Psychol; 2021 May; 17():465-493. PubMed ID: 33472009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From neuroscience to evidence based psychological treatments - The promise and the challenge, ECNP March 2016, Nice, France.
    Goodwin GM; Holmes EA; Andersson E; Browning M; Jones A; Lass-Hennemann J; Månsson KN; Moessnang C; Salemink E; Sanchez A; van Zutphen L; Visser RM
    Eur Neuropsychopharmacol; 2018 Feb; 28(2):317-333. PubMed ID: 29371024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability to relapse under stress: insights from affective neuroscience.
    Pool ER; Sander D
    Swiss Med Wkly; 2019 Nov; 149():w20151. PubMed ID: 31782510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychology and neurobiology of addiction: an incentive-sensitization view.
    Robinson TE; Berridge KC
    Addiction; 2000 Aug; 95 Suppl 2():S91-117. PubMed ID: 11002906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction.
    Morgenstern J; Naqvi NH; Debellis R; Breiter HC
    Psychol Addict Behav; 2013 Jun; 27(2):336-50. PubMed ID: 23586452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology in the age of circuit neuroscience: Illuminating the neural mechanisms of reward, drug use and addiction and enlightening the future of translational research.
    Jordan CJ; Wise R; Xi ZX
    Pharmacol Biochem Behav; 2021 Jul; 206():173187. PubMed ID: 33872665
    [No Abstract]   [Full Text] [Related]  

  • 7. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
    Patrono E; Gasbarri A; Tomaz C; Nishijo H
    Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.
    Yücel M; Oldenhof E; Ahmed SH; Belin D; Billieux J; Bowden-Jones H; Carter A; Chamberlain SR; Clark L; Connor J; Daglish M; Dom G; Dannon P; Duka T; Fernandez-Serrano MJ; Field M; Franken I; Goldstein RZ; Gonzalez R; Goudriaan AE; Grant JE; Gullo MJ; Hester R; Hodgins DC; Le Foll B; Lee RSC; Lingford-Hughes A; Lorenzetti V; Moeller SJ; Munafò MR; Odlaug B; Potenza MN; Segrave R; Sjoerds Z; Solowij N; van den Brink W; van Holst RJ; Voon V; Wiers R; Fontenelle LF; Verdejo-Garcia A
    Addiction; 2019 Jun; 114(6):1095-1109. PubMed ID: 30133930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective.
    Ekhtiari H; Rezapour T; Aupperle RL; Paulus MP
    Prog Brain Res; 2017; 235():239-264. PubMed ID: 29054291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural imaginaries at work: Exploring Australian addiction treatment providers' selective representations of the brain in clinical practice.
    Barnett AI; Pickersgill M; Dilkes-Frayne E; Carter A
    Soc Sci Med; 2020 Jun; 255():112977. PubMed ID: 32371268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in behavioral activation: Using findings from basic science and translational neuroscience to inform the exploration of potential mechanisms of change.
    Forbes CN
    Clin Psychol Rev; 2020 Jul; 79():101860. PubMed ID: 32413734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness training for addictions: has neuroscience revealed a brain hack by which awareness subverts the addictive process?
    Brewer J
    Curr Opin Psychol; 2019 Aug; 28():198-203. PubMed ID: 30785066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate versus psychostimulant addiction: the differences do matter.
    Badiani A; Belin D; Epstein D; Calu D; Shaham Y
    Nat Rev Neurosci; 2011 Oct; 12(11):685-700. PubMed ID: 21971065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging the gap between the neurocognitive lab and the addiction clinic.
    Franken IHA; van de Wetering BJM
    Addict Behav; 2015 May; 44():108-114. PubMed ID: 25500167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroscience in addiction research.
    Valentino RJ; Nair SG; Volkow ND
    J Neural Transm (Vienna); 2024 May; 131(5):453-459. PubMed ID: 37947883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychological science of addiction.
    Gifford E; Humphreys K
    Addiction; 2007 Mar; 102(3):352-61. PubMed ID: 17298641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological Interventions for Decision-Making in Addiction: a Systematic Review.
    Verdejo-García A; Alcázar-Córcoles MA; Albein-Urios N
    Neuropsychol Rev; 2019 Mar; 29(1):79-92. PubMed ID: 30259388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroeconomics and the study of addiction.
    Monterosso J; Piray P; Luo S
    Biol Psychiatry; 2012 Jul; 72(2):107-12. PubMed ID: 22520343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating genetics, cognitive science, and other basic science research findings into applications for prevention.
    Ames SL; McBride C
    Eval Health Prof; 2006 Sep; 29(3):277-301. PubMed ID: 16868339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug addiction, dysregulation of reward, and allostasis.
    Koob GF; Le Moal M
    Neuropsychopharmacology; 2001 Feb; 24(2):97-129. PubMed ID: 11120394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.